Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
12.92
-0.02 (-0.15%)
At close: May 16, 2025, 4:00 PM
12.92
0.00 (0.00%)
After-hours: May 16, 2025, 7:00 PM EDT
Elanco Animal Health Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for Elanco Animal Health stock ranges from a low of $12 to a high of $19. The average analyst price target of $15 forecasts a 16.10% increase in the stock price over the next year.
Price Target: $15.00 (+16.10%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Elanco Animal Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 0 | 0 | 0 |
Total | 8 | 7 | 7 | 6 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stifel | Stifel | Strong Buy Maintains $13 → $15 | Strong Buy | Maintains | $13 → $15 | +16.10% | May 8, 2025 |
Stifel | Stifel | Strong Buy Maintains $15 → $13 | Strong Buy | Maintains | $15 → $13 | +0.62% | Apr 14, 2025 |
Piper Sandler | Piper Sandler | Hold Maintains $16 → $12 | Hold | Maintains | $16 → $12 | -7.12% | Mar 6, 2025 |
UBS | UBS | Strong Buy Maintains $18 → $17 | Strong Buy | Maintains | $18 → $17 | +31.58% | Feb 26, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $14 → $13 | Hold | Maintains | $14 → $13 | +0.62% | Feb 26, 2025 |
Financial Forecast
Revenue This Year
4.60B
from 4.44B
Increased by 3.67%
Revenue Next Year
4.81B
from 4.60B
Increased by 4.56%
EPS This Year
0.84
from 0.68
Increased by 23.39%
EPS Next Year
0.97
from 0.84
Increased by 16.16%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.8B | 5.0B | 5.2B | ||
Avg | 4.6B | 4.8B | 5.0B | ||
Low | 4.4B | 4.5B | 4.7B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 8.0% | 9.4% | 8.9% | ||
Avg | 3.7% | 4.6% | 3.9% | ||
Low | -1.8% | -1.4% | -2.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 0.90 | 1.05 | 1.22 | ||
Avg | 0.84 | 0.97 | 1.11 | ||
Low | 0.78 | 0.84 | 0.96 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 32.8% | 25.1% | 25.0% | ||
Avg | 23.4% | 16.2% | 13.7% | ||
Low | 15.3% | 0.4% | -1.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.